Overall rank by patents
#24,913
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Oertli-instrumente Ag
USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
11
Total patents granted
4
CPC technology areas
6.2
Avg claims per patent
+20%
5-year filing velocity
The verdict
Oertli-instrumente holds 11 US patents across 4 technology areas, rank #24,913 of 50,000 tracked assignees.
- #24,913
- of 50,000 US assignees by volume
- Top 90%
- by Innovation Score (22.0/100)
- 6.2
- avg claims per patent
- +20%
- filing velocity, last 5 yrs
Portfolio overview
Oertli-instrumente Ag has been granted 11 US utility patents between 2015 and 2023, placing Oertli-instrumente Ag at rank #24,913 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 6.2 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, Oertli-instrumente Ag is one of the more focused assignees in the PatentsView dataset. By volume, Oertli-instrumente sits between Odawara Engineering Co., Ltd. (11 patents, rank #24,909) and OMNI LPS. Co., Ltd. (11 patents, rank #24,917) - the closest US assignees by grant volume. The composite Innovation Score of 22.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 5 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Oertli-instrumente Ag's 6.2 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Oertli-instrumente Ag against peers pursuing similar technology classes.
Who files at Oertli-instrumente's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Odawara Engineeri…
ODAWARA ENGINEERING CO., LTD.
11 patents
- Odessa Separator
ODESSA SEPARATOR, INC.
11 patents
- Oechsler
OECHSLER AG
11 patents
- Oeconnection
OECONNECTION LLC
11 patents
- OFI Testing Equip…
OFI Testing Equipment, Inc.
11 patents
- Okazaki Manufactu…
OKAZAKI MANUFACTURING COMPANY
11 patents
- OMNI Cubed
OMNI CUBED, Inc.
11 patents
- OMNI LPS
OMNI LPS. CO., LTD.
11 patents
- Oertli-instrumente ◀
OERTLI-INSTRUMENTE AG
11 patents
What this shows Oertli-instrumente holds 11 patents at rank #24,913, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Oertli-instrumente's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
22 Top 90% higher than 10% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 18.2% |
| 2016 | 1 | 9.1% |
| 2018 | 1 | 9.1% |
| 2019 | 1 | 9.1% |
| 2021 | 4 | 36.4% |
| 2022 | 1 | 9.1% |
| 2023 | 1 | 9.1% |
Which technologies does Oertli-instrumente Ag patent most?
Top 4 of 4 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple
Velocity Growing
Frequently Asked Questions
How many patents does Oertli-instrumente Ag hold?
Oertli-instrumente Ag holds 11 US granted patents filed between 2015 and 2023, spanning 4 technology areas.
What is Oertli-instrumente Ag's Innovation Score?
Oertli-instrumente Ag has an Innovation Score of 22.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Oertli-instrumente Ag focus on?
Oertli-instrumente Ag's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 3 patents. The company has filed patents in 4 CPC subclasses total.
Is Oertli-instrumente Ag's patent filing rate increasing or decreasing?
Oertli-instrumente Ag's recent filing velocity is +20% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Oertli-instrumente Ag's patents?
Oertli-instrumente Ag's patents average 6.2 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Oertli-instrumente Ag patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Oertli-instrumente's 11 grants land it in the top 90% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Oertli-instrumente ranks #24,913 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.